Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Patent
1995-11-22
1998-03-31
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
514743, 514886, 514887, 514959, A61K 3102
Patent
active
057339392
ABSTRACT:
A method for reducing the inflammatory response in tissues of a patient, by contacting the tissue with an effective, inflammation-reducing amount of a liquid or gaseous fluorocarbon.
REFERENCES:
patent: 4044121 (1977-08-01), Ko
patent: 4490351 (1984-12-01), Clark, Jr.
patent: 4543202 (1985-09-01), Bartlett et al.
patent: 4680173 (1987-07-01), Burger
patent: 4865836 (1989-09-01), Long, Jr.
patent: 4897262 (1990-01-01), Nandagiri et al.
patent: 4927623 (1990-05-01), Long, Jr.
patent: 4987154 (1991-01-01), Long, Jr.
patent: 5028428 (1991-07-01), Smith et al.
patent: 5192528 (1993-03-01), Radhakrishnan et al.
patent: 5213570 (1993-05-01), VanDeripe
patent: 5225183 (1993-07-01), Purewal et al.
patent: 5284645 (1994-02-01), Long, Jr.
patent: 5290540 (1994-03-01), Prince et al.
patent: 5437272 (1995-08-01), Fuhrman
patent: 5470885 (1995-11-01), Fuhrman et al.
patent: 5490498 (1996-02-01), Faithfull et al.
Smith, K.M. et al., Pediatric Research, vol. 37(4, pt. 2), p. 305A, abstract #2086, 1994.
Nesti, F.D. et al., Critical Care Medicine, vol. 22(9), pp. 1445-1452, 1994.
Barry, B.E. et al., Am. Rev. Respir. Dis., vol. 138(2), pp. 435-444, Aug. 1988
Ohnishi, Y. et al., Acta Pathol. Jpn., vol. 30(3), pp. 489-504, May 1980.
Smith, T.M. et al., Critical Care Medicine, vol. 23(9), pp. 1533-1539, Sep. 1995.
Lane, T. et al., Biomat., Art. Cells & Immob. Biotech., vol. 21(2), pp. 163-172, 1993.
Hirschl, R.B. et al., Surgery, vol. 116(2), pp. 159-168, Aug. 1994.
Jean G. Riess, "Reassessment of Criteria for the Selection of Perfluorochemicals for Second-Generation Blood Substitutes: Analysis of Structure/Property Relationships", Artificial Organs 8:1 pp. 44-56, 1984.
Hirschl, et al., The FASEB Journal 7(3): p. A229, 1993, abstract #1322.
Calderwood, et al., "Residual Levels and Biochemical Changes After Ventilation with Perfluorinated Liquid", J. Appl. Physiol., 39:4, pp. 603-607, 1975, Oct.
Modell, et al., "Liquid Ventilation of Primates", Chest 69: pp. 79-81, 1976 Jan.
Modell, et al., "Long-Term Survival of Dogs After Breathing Oxygenated Fluorocarbon Liquid", Federation Proceedings 29:5 pp. 1731-1739, 1970 Sep.-Oct.
Flaim Stephen F.
Fuhrman Bradley Phillip
Hernan Lynn Joanne
Nesti Frances Darey
Papo Michele Cecile
Alliance Pharmaceutical Corp.
Sayala Chhaya D.
LandOfFree
Fluorocarbons as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorocarbons as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorocarbons as anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-52543